Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis

MH Forouzanfar, KJ Foreman, AM Delossantos… - The lancet, 2011 - thelancet.com
Background Breast and cervical cancer are important causes of mortality in women aged≥
15 years. We undertook annual age-specific assessments of breast and cervical cancer in …

The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies

M Broeders, S Moss, L Nyström, S Njor… - Journal of medical …, 2012 - journals.sagepub.com
Objectives To assess the impact of population-based mammographic screening on breast
cancer mortality in Europe, considering different methodologies and limitations of the data …

Screening for breast cancer with mammography

PC Gøtzsche, KJ Jørgensen - Cochrane database of …, 2013 - cochranelibrary.com
Screening for breast cancer with mammography - Gøtzsche, PC - 2013 | Cochrane Library Skip
to Content Cookies Our site uses cookies to improve your experience. You can find out more …

Effect of screening and adjuvant therapy on mortality from breast cancer

DA Berry, KA Cronin, SK Plevritis… - … England Journal of …, 2005 - Mass Medical Soc
Background We used modeling techniques to assess the relative and absolute contributions
of screening mammography and adjuvant treatment to the reduction in breast-cancer …

Revisiting time to translation: implementation of evidence-based practices (EBPs) in cancer control

S Khan, D Chambers, G Neta - Cancer Causes & Control, 2021 - Springer
Purpose Previous studies estimate translation of research evidence into practice takes 17
years. However, this estimate is not specific to cancer control evidence-based practices …

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

M Kriege, CTM Brekelmans, C Boetes… - … England Journal of …, 2004 - Mass Medical Soc
Background The value of regular surveillance for breast cancer in women with a genetic or
familial predisposition to breast cancer is currently unproven. We compared the efficacy of …

Selling sickness: the pharmaceutical industry and disease mongeringCommentary: Medicalisation of risk factors

R Moynihan, P CG, I Heath, D Henry - Bmj, 2002 - bmj.com
A lot of money can be made from healthy people who believe they are sick. Pharmaceutical
companies sponsor diseases and promote them to prescribers and consumers. Ray …

[图书][B] Synthesising qualitative and quantitative health evidence: A guide to methods: A guide to methods

C Pope, N Mays, J Popay - 2007 - books.google.com
Provides a comprehensive overview of range of approaches and methods available for
synthesising qualitative and quantitative evidence and an explanation of why this is …

Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force

LL Humphrey, M Helfand, BKS Chan… - Annals of internal …, 2002 - acpjournals.org
Purpose: To synthesize new data on breast cancer screening for the US Preventive Services
Task Force. Data Sources: MEDLINE; the Cochrane Controlled Trials Registry; and …

Screening for breast cancer

JG Elmore, K Armstrong, CD Lehman, SW Fletcher - Jama, 2005 - jamanetwork.com
ContextBreast cancer screening in community practices may be different from that in
randomized controlled trials. New screening modalities are becoming available …